Simbol EBS | |
Simbol | EBS |
Simbol eToro | EBS |
MarketWatch | EBS |
Finviz | EBS |
Yahoo Finance | EBS |
Google Finance | EBS |
TradingView | EBS |
Investing.com | EBS |
Denumire | Emergent BioSolutions Inc. |
Website | emergentbiosolutions.com |
Piața | NYSE |
ISIN | US29089Q1058 |
Sector | Health Technology |
Industrie | Pharmaceuticals Major |
Monedă | USD |
Preț | 8,2500 USD |
Capitalizare bursieră | 0,416 mld. USD |
P/E | -1,02 |
Beta | 1,4094 |
EPS | -8,0540 |
Profit anual | -70,94% |
Dată actualizare | 12.06.2023 |
Descriere |
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri in May 1998 and is headquartered in Gaithersburg, MD. |
Data | P/E | Beta | Capitalizare | Dividend | EPS | Profit anual | Preț |
29.11.2021 | 10,59 | 1,0406 | 2,380 | 0,00% | 4,1758 | -46,26% | $44,21 |
12.06.2023 | -1,02 | 1,4094 | 0,416 | 0,00% | -8,0540 | -70,94% | $8,25 |